TickerFacts.

Vivos Therapeutics, Inc. (VVOS): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$17.60M
Year ended 2025-12-31
-$19.01M
Trailing 12 months to 2026-06-30
2019-12-31: -$5.52M2020-12-31: -$5.80M2021-12-31: -$18.13M2022-12-31: -$20.51M2023-12-31: -$12.75M2024-12-31: -$13.26M2025-12-31: -$17.60M-$17.60M
2019-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$17.60Mn/m2026-04-15, From 2025-01-01
2024-12-31-$13.26Mn/m2026-04-15, From 2024-01-01
2023-12-31-$12.75Mn/m2025-03-31, From 2023-01-01
2022-12-31-$20.51Mn/m2024-07-30, From 2022-01-01
2021-12-31-$18.13Mn/m2023-03-30, From 2021-01-01
2020-12-31-$5.80Mn/m2022-03-31, From 2020-01-01
2019-12-31-$5.52Mn/a2021-03-25, From 2019-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$17.60Mn/m
Nephros Inc (NEPH)2024-12-31-$555.0Kn/a
Profound Medical Corp. (PROF)2025-12-31-$38.38Mn/a
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31-$4.12Mn/m
Allurion Technologies, Inc. (ALUR)2024-12-31-$42.91Mn/m
DarioHealth Corp. (DRIO)2025-12-31-$26.08Mn/m
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31-$1.39Mn/m
Nexgel, Inc. (NXGL)2025-12-31-$1.38Mn/m
Sensus Healthcare, Inc. (SRTS)2025-12-31$332.0Kn/m

Compare VVOS, NEPH, PROF, SNOA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗